Clinical failure of vancomycin in a dialysis patient with methicillin-susceptible vancomycin-heteroresistant S. aureus.
暂无分享,去创建一个
Elizabeth L. Alexander | S. Jenkins | K. Rhee | B. Kreiswirth | A. Schuetz | J. Mediavilla | Dahlene N. Fusco | S. Weisenberg | Scott A Weisenberg
[1] Ronald N. Jones,et al. Characterization of Vancomycin-Heteroresistant Staphylococcus aureus from the Metropolitan Area of Detroit, Michigan, over a 22-Year Period (1986 to 2007) , 2008, Journal of Clinical Microbiology.
[2] A. Rossney,et al. Evaluation of the Xpert Methicillin-Resistant Staphylococcus aureus (MRSA) Assay Using the GeneXpert Real-Time PCR Platform for Rapid Detection of MRSA from Screening Specimens , 2008, Journal of Clinical Microbiology.
[3] Ronald N. Jones,et al. Characterization of Vancomycin-Heteroresistant Staphylococcus aureus from the Metropolitan Area of Detroit, Michigan, over a 22-Year Period (1986 to 2007) , 2008, Journal of Clinical Microbiology.
[4] M. Wootton,et al. Evaluation of a New Etest Vancomycin-Teicoplanin Strip for Detection of Glycopeptide-Intermediate Staphylococcus aureus (GISA), in Particular, Heterogeneous GISA , 2008, Journal of Clinical Microbiology.
[5] R. Moellering,et al. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] A. MacGowan,et al. A Multicenter Study Evaluating the Current Strategies for Isolating Staphylococcus aureus Strains with Reduced Susceptibility to Glycopeptides , 2006, Journal of Clinical Microbiology.
[7] Bruno Hoen,et al. Staphylococcus aureus endocarditis: a consequence of medical progress. , 2005, JAMA.
[8] J. Schrenzel,et al. Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains. , 2004, Journal of microbiological methods.
[9] P. Ward,et al. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] M. Mulvey,et al. Development of a Canadian Standardized Protocol for Subtyping Methicillin-Resistant Staphylococcus aureus Using Pulsed-Field Gel Electrophoresis , 2001, Journal of Clinical Microbiology.
[11] F. Vandenesch,et al. Clinical Isolate of Vancomycin-HeterointermediateStaphylococcus aureus Susceptible to Methicillin and In Vitro Selection of a Vancomycin-Resistant Derivative , 2001, Antimicrobial Agents and Chemotherapy.
[12] A. Tomasz,et al. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. , 1999, The New England journal of medicine.
[13] F. Tenover,et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. , 1997, The Journal of antimicrobial chemotherapy.